Clinical pharmacology of psychotropic drugs.

Psychotropic drugs are chemical agents that act on the central nervous system (CNS) to influence brain function, resulting in alterations in mood, perception, behavior, and cognition. They are primarily used in the management of psychiatric disorders such as depression, schizophrenia, bipolar disorder, anxiety, and sleep disturbances. These drugs are broadly classified into antipsychotics, antidepressants, mood stabilizers, anxiolytics, hypnotics, psychostimulants, and cognitive enhancers. Their mechanisms of action involve modulation of neurotransmitters like dopamine, serotonin, norepinephrine, gamma-aminobutyric acid (GABA), acetylcholine, and glutamate. For example, antipsychotics mainly block dopamine (D₂) receptors to reduce psychotic symptoms; antidepressants such as selective serotonin reuptake inhibitors (SSRIs) increase serotonin levels to improve mood; mood stabilizers like lithium alter neuronal excitability and intracellular signaling; and anxiolytics such as benzodiazepines enhance GABAergic transmission to produce calming effects. Pharmacokinetically, most psychotropic drugs are well absorbed orally, highly lipid-soluble (allowing easy penetration across the blood-brain barrier), and extensively metabolized in the liver by cytochrome P450 enzymes. Adverse effects vary with drug class and may include sedation, weight gain, sexual dysfunction, extrapyramidal symptoms, or metabolic disturbances. Clinical use requires careful dose titration, therapeutic drug monitoring (especially for lithium and valproate), and regular patient follow-up to ensure safety and adherence. Overall, psychotropic drugs play a crucial role in improving the quality of life in patients with mental illnesses when used judiciously under medical supervision.